Protagenic Therapeutics, Inc. (PTIX)
$0.80-1.23%Close
SELLRECOVERY · day 3
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $1M
- Beta
- 1.07
- P/E (TTM)
- 0.27
- Short % float
- 0.75%
- Days to cover
- 1.2
- SI change
- +0.4%
- 1W
- +3.90%
- 1M
- +1.27%
- vs SPY 1W
- +4.88%
- vs SPY 1M
- -0.60%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 8
- VALUE
- 21
- GROWTH
- 35
- GARP
- 0
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-
REV YoY-
ROE-
EPS YoY-
ROA261.8%
GROSS0
OP0
NET0
[VALUATION]
P/E TTM0.27
P/E FWD-
SECTOR PE20.48
INDUSTRY PE13.99
P/B0.84
P/FCF-
EV/EBITDA-0.22
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E-
ALTMAN Z-
CURR RATIO0.66
ND/EBITDA-
BETA1.07
Company news
FAQ
- What is LOPJLB’s current signal on PTIX?
- LOPJLB’s latest quantitative signal on Protagenic Therapeutics, Inc. (PTIX) is SELL in a RECOVERY regime. Signals are updated daily.
- What market regime is PTIX in?
- Protagenic Therapeutics, Inc. (PTIX) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Protagenic Therapeutics, Inc. (PTIX) do?
- Protagenic Therapeutics, Inc. operates as a pharmaceutical company specializing in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules. Protagenic Therapeutics, Inc. was founded in 2004 and is based in Santa Barbara, California.